L. Trentini

550 total citations
25 papers, 354 citations indexed

About

L. Trentini is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, L. Trentini has authored 25 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 12 papers in Virology and 5 papers in Epidemiology. Recurrent topics in L. Trentini's work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (12 papers) and HIV/AIDS Research and Interventions (9 papers). L. Trentini is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (12 papers) and HIV/AIDS Research and Interventions (9 papers). L. Trentini collaborates with scholars based in Italy, United Kingdom and Israel. L. Trentini's co-authors include Giovanni Di Perri, Stefano Bonora, Antonio D’Avolio, Mauro Sciandra, Andrea Calcagno, Lorena Baietto, Marco Siccardi, Jessica Cusato, Marco Simiele and Letizia Marinaro and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Emerging infectious diseases and AIDS.

In The Last Decade

L. Trentini

25 papers receiving 344 citations

Peers

L. Trentini
Andrew Luber United States
Rosa Ruiz-Valderas Spain
Steve West United States
Charles Wakeford United States
Amelia S. Petry United States
Patricia K. Mydlow United States
Gema González‐Pardo Spain
Yoninah Cramer United States
I Jiménez‐Nácher Spain
Michael Zilly Germany
Andrew Luber United States
L. Trentini
Citations per year, relative to L. Trentini L. Trentini (= 1×) peers Andrew Luber

Countries citing papers authored by L. Trentini

Since Specialization
Citations

This map shows the geographic impact of L. Trentini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Trentini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Trentini more than expected).

Fields of papers citing papers by L. Trentini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Trentini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Trentini. The network helps show where L. Trentini may publish in the future.

Co-authorship network of co-authors of L. Trentini

This figure shows the co-authorship network connecting the top 25 collaborators of L. Trentini. A scholar is included among the top collaborators of L. Trentini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Trentini. L. Trentini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bioletto, Fabio, et al.. (2022). Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV. Nutrition Metabolism and Cardiovascular Diseases. 32(8). 1936–1943. 2 indexed citations
2.
Calcagno, Andrea, Amedeo De Nicolò, Costanza Pizzi, et al.. (2021). Medication burden and clustering in people living with HIV undergoing therapeutic drug monitoring. British Journal of Clinical Pharmacology. 87(11). 4432–4438. 5 indexed citations
3.
Calcagno, Andrea, Daniela Zugna, Jessica Cusato, et al.. (2018). Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?. The Pharmacogenomics Journal. 19(1). 65–71. 7 indexed citations
4.
Focà, Emanuele, Andrea Calcagno, Marco Simiele, et al.. (2017). Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients. Journal of Antimicrobial Chemotherapy. 72(11). 3163–3166. 6 indexed citations
5.
Calcagno, Andrea, Nicole Pagani, Alessandra Ariaudo, et al.. (2017). Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failure. Journal of Antimicrobial Chemotherapy. 72(6). 1741–1744. 8 indexed citations
6.
Marinaro, Letizia, Andrea Calcagno, Diego Ripamonti, et al.. (2016). Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. Journal of Clinical Virology. 87. 30–36. 4 indexed citations
7.
Macori, Guerrino, Silvia Gallina, Martina Giusti, et al.. (2016). Coagulase positive staphylococci and food poisoning toxins - A case study of an outbreak investigation occurred in a sheperd hut. International Journal of Infectious Diseases. 45. 464–464. 3 indexed citations
8.
Calcagno, Andrea, Jessica Cusato, Letizia Marinaro, et al.. (2015). Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines. The Pharmacogenomics Journal. 16(6). 514–518. 26 indexed citations
9.
Calcagno, Andrea, Ilaria Motta, Valeria Ghisetti, et al.. (2015). HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients. AIDS Research and Human Retroviruses. 31(10). 999–1008. 18 indexed citations
10.
Calcagno, Andrea, Chiara Montrucchio, Amedeo Capetti, et al.. (2015). Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics. Current HIV Research. 14(1). 54–60. 6 indexed citations
11.
Calcagno, Andrea, Jessica Cusato, Letizia Marinaro, et al.. (2015). Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairment. AIDS. 30(6). 915–920. 12 indexed citations
12.
Bonora, Stefano, Andrea Calcagno, Ottavia Viganò, et al.. (2014). Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients. Current HIV Research. 12(5). 339–346. 5 indexed citations
13.
D’Avolio, Antonio, Chiara Carcieri, Jessica Cusato, et al.. (2014). Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. Journal of Antimicrobial Chemotherapy. 69(11). 3061–3066. 36 indexed citations
14.
D’Avolio, Antonio, Marco Simiele, Andrea Calcagno, et al.. (2012). Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells. Journal of Antimicrobial Chemotherapy. 68(4). 907–910. 21 indexed citations
15.
Bonora, Stefano, Daniel González de Requena, Antonio D’Avolio, et al.. (2011). Pharmacokinetics of Switching Unboosted Atazanavir Coadministered with Tenofovir Disoproxil Fumarate from 400 Mg Once Daily to 200 Mg Twice Daily in HIV-Positive Patients. Antiviral Therapy. 16(4). 499–504. 9 indexed citations
16.
Requena, Daniel González de, Stefano Bonora, Antonio D’Avolio, et al.. (2008). The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon. Journal of Antimicrobial Chemotherapy. 61(4). 919–924. 35 indexed citations
17.
Bonora, Stefano, Alessandra Mondo, L. Trentini, et al.. (2008). Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins. Journal of Infection. 57(1). 78–81. 11 indexed citations
18.
Bonora, Stefano, Antonella Castagna, Hamid Hasson, et al.. (2008). Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients. Journal of Antimicrobial Chemotherapy. 62(2). 384–387. 7 indexed citations
19.
Bonora, Stefano, Antonio D’Avolio, Marco Siccardi, et al.. (2008). A pilot study evaluating plasma and intracellular pharmacokinetics (PK) of switching from atazanavir (ATV) 400mg QD to ATV 200 mg BID in HIV+ patients.. 1. 1 indexed citations
20.
Gobbi, Federico, et al.. (2005). Blackwater Fever in Children, Burundi. Emerging infectious diseases. 11(7). 1118–1120. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Luber Breakdown of academic impact, for papers by Rosa Ruiz-Valderas Breakdown of academic impact, for papers by Steve West Breakdown of academic impact, for papers by Charles Wakeford Breakdown of academic impact, for papers by Amelia S. Petry Breakdown of academic impact, for papers by Patricia K. Mydlow Breakdown of academic impact, for papers by Gema González‐Pardo Breakdown of academic impact, for papers by Yoninah Cramer Breakdown of academic impact, for papers by I Jiménez‐Nácher Breakdown of academic impact, for papers by Michael Zilly
Rankless by CCL
2026